Jaguar Health (JAGX) Return on Equity (2016 - 2025)
Jaguar Health (JAGX) has disclosed Return on Equity for 11 consecutive years, with 5.49% as the latest value for Q3 2025.
- On a quarterly basis, Return on Equity fell 310.0% to 5.49% in Q3 2025 year-over-year; TTM through Sep 2025 was 5.49%, a 310.0% decrease, with the full-year FY2024 number at 6.89%, up 1679.0% from a year prior.
- Return on Equity was 5.49% for Q3 2025 at Jaguar Health, up from 7.97% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 1.34% in Q2 2021 to a low of 43.21% in Q4 2022.
- A 5-year average of 8.62% and a median of 5.89% in 2022 define the central range for Return on Equity.
- Peak YoY movement for Return on Equity: plummeted -4006bps in 2022, then skyrocketed 2994bps in 2023.
- Jaguar Health's Return on Equity stood at 3.15% in 2021, then plummeted by -1272bps to 43.21% in 2022, then soared by 69bps to 13.27% in 2023, then skyrocketed by 76bps to 3.18% in 2024, then tumbled by -73bps to 5.49% in 2025.
- Per Business Quant, the three most recent readings for JAGX's Return on Equity are 5.49% (Q3 2025), 7.97% (Q2 2025), and 8.83% (Q1 2025).